|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.290 NOK | 0.00% |
|
-2.66% | +36.40% |
| 08-06 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
| 08-04 | Nykode Therapeutics Flags Delay in Draft Recommendation for Tax Appeal in Norway | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | -2.66% | +15.03% | +5.11% | +36.40% | +97.01% | -88.92% | -95.51% | - | 114M | |
| -0.70% | +13.34% | +29.94% | +47.36% | +76.75% | +75.61% | +103.83% | +11.64% | - | 70.85B | |
| -2.35% | +2.88% | -1.94% | +8.36% | +4.49% | +35.39% | +64.72% | +182.22% | +5,427.68% | 55.41B | |
| -1.62% | +34.25% | +14.67% | +27.61% | -23.83% | +17.43% | +491.04% | +444.21% | +1,041.86% | 29.43B | |
| -0.30% | +13.64% | +21.13% | +39.08% | +46.25% | +54.71% | +6.07% | -62.77% | - | 24.12B | |
| 0.00% | +1.59% | +1.43% | -0.58% | -2.52% | -15.06% | -13.21% | -74.16% | - | 23.31B | |
| +0.05% | +6.12% | +6.66% | +20.13% | -1.68% | +46.81% | -21.81% | -29.85% | +70.34% | 18.37B | |
| +9.77% | +20.16% | +13.62% | +129.40% | +244.58% | +260.17% | +472.38% | +1,840.89% | +871.49% | 16.99B | |
| 0.00% | +9.69% | +2.32% | +17.65% | +34.75% | +31.01% | +584.59% | - | - | 16.1B | |
| -3.08% | -8.34% | -9.15% | +3.26% | +17.11% | +37.21% | +138.52% | +194.15% | +381.52% | 13.12B | |
| +1.03% | -0.39% | +16.81% | +14.79% | +34.42% | +418.54% | +209.32% | +51.38% | +1,454.70% | 12.48B | |
| +0.39% | +8.58% | +4.78% | -22.39% | -9.82% | -36.63% | +203.73% | +114.08% | - | 11.92B | |
| +3.87% | +5.46% | -0.27% | +7.69% | -8.08% | +53.15% | +212.24% | +532.26% | +7,172.69% | 11.91B | |
| +1.65% | +9.85% | -0.89% | -19.00% | -13.58% | -46.50% | +778.78% | +94.28% | +113.49% | 11.86B | |
| -1.34% | -2.75% | -9.92% | +2.53% | +20.32% | +130.06% | +133.44% | +135.01% | +528.18% | 10.77B | |
| -1.24% | +3.98% | -0.48% | -14.90% | +16.25% | +25.77% | +122.61% | -31.17% | - | 9.29B | |
| -2.46% | -2.10% | +5.12% | +34.42% | +213.61% | +573.70% | +721.92% | -36.68% | -10.47% | 9.29B | |
| +0.25% | +0.60% | +0.93% | +130.81% | +81.22% | +208.11% | +410.81% | +341.21% | - | 8.93B | |
| +1.60% | +8.28% | +1.74% | +9.69% | +28.35% | +99.60% | +25.44% | +132.42% | - | 8.67B | |
| +1.47% | +9.35% | -7.54% | -6.29% | +283.84% | +207.69% | +315.30% | -32.50% | - | 7.94B | |
| Average | +0.35% | +232.76% | +5.20% | +21.74% | +53.94% | +113.69% | +243.54% | +195.32% | +1,705.15% | 18.54B | |
| Weighted average by Cap. | -0.12% | +286.63% | +9.20% | +26.02% | +44.73% | +84.35% | +206.41% | +192.33% | +2,441.59% |
- Stock Market
- Stocks
- NYKD Stock
- Sector Nykode Therapeutics
Select your edition
All financial news and data tailored to specific country editions
